MARLBOROUGH, Mass. , Aug. 10, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Wells Fargo's 21 st Annual Healthcare Conference on Thursday, September 10,...
Boston Scientific’s Q2 Earnings Call: Our Top 5 Analyst Questions
ALAMEDA, Calif. , July 30, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the second quarter ended June 30, 2026....
/Boston%20Scientific%20sign%20at%20manufacturer%20of%20medical%20devices%20Silicon%20Valley%20office%20By%20MichaelVi.jpeg)
Boston Scientific underperformed the broader market, though analysts remain optimistic, citing strong earnings execution, innovation, and meaningful upside from current levels.
BSX Q2 Deep Dive: WATCHMAN and Electrophysiology Challenges Temper Growth Outlook
2 Profitable Stocks to Keep an Eye On and 1 We Turn Down
Boston Scientific (NYSE:BSX) Surprises With Q2 CY2026 Sales But Quarterly Revenue Guidance Misses Expectations
Boston Scientific: Q2 Earnings Snapshot
MARLBOROUGH, Mass. , July 29, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.442 billion during the second quarter of 2026, growing 7.5 percent on a reported...
Barchart Research What to Expect from BSX Earnings BSX Generated July 28, 2026 Current Price $46.06 EPS Estimate $$0.83 Consensus Rating Strong Buy Average Move 5.27% Boston Scientific's Restructuring...